Heart diseasestill claims the lives of around 600,000 Americans every year, and uncontrollable cholesterol plays a big role.EsperionTherapeutics Inc. (NASDAQ:ESPR)became oneof2017’s best-performing biotech stocks because it’s developing a drug that could lower this number.
Unfortunately, Esperion recently revealed some disturbing safety data from one of several ongoing late-stage clinical trials. The stock price was quickly cut in half, and there’s still a chance it could come back in a big way.
Does that make this risky biotech a buy on the dip?Let’s weigh opportunities against apparent risks to see if this stock makes sense at its new low price.
Image source: Getty Images.
Reasons to buy
Before Lipitor lost patent protection, it raked in $13 billion annually for Pfizer, and several similar drugs in the statin family were big sellers in their day. This class of drug is usually effective, but unpleasant side effects such as muscle weakness affect most patients to some degree. An estimated 15% of people treated for high cholesterol can’t get their scores low enough with statins because some form of intolerance limits their dosage.
Top Low Price Stocks To Buy Right Now: Colliers International Group Inc. (CIGI)
Advisors’ Opinion:
- [By Joseph Griffin]
Colliers International Gr (NASDAQ: CIGI) and Getty Realty (NYSE:GTY) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
- [By Joseph Griffin]
A number of hedge funds have recently made changes to their positions in the business. Beutel Goodman & Co Ltd. acquired a new position in Colliers International Gr during the fourth quarter valued at approximately $117,633,000. Renaissance Technologies LLC lifted its position in Colliers International Gr by 4.5% during the fourth quarter. Renaissance Technologies LLC now owns 859,200 shares of the financial services provider’s stock valued at $51,856,000 after buying an additional 36,800 shares in the last quarter. Mackenzie Financial Corp lifted its position in Colliers International Gr by 305.1% during the fourth quarter. Mackenzie Financial Corp now owns 305,329 shares of the financial services provider’s stock valued at $18,427,000 after buying an additional 229,960 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in Colliers International Gr by 31.6% during the fourth quarter. The Manufacturers Life Insurance Company now owns 261,450 shares of the financial services provider’s stock valued at $15,779,000 after buying an additional 62,834 shares in the last quarter. Finally, Deutsche Bank AG lifted its position in Colliers International Gr by 25.2% during the fourth quarter. Deutsche Bank AG now owns 234,768 shares of the financial services provider’s stock valued at $14,168,000 after buying an additional 47,253 shares in the last quarter. 72.69% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Colliers International Gr (CIGI) Lifted to Hold at Zacks Investment Research” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright legislation. The legal version of this piece of content can be read at www.tickerreport.com/bankin
- [By Ethan Ryder]
Seritage Growth Properties Class A (NYSE: SRG) and Colliers International Group (NASDAQ:CIGI) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.
- [By Logan Wallace]
BidaskClub lowered shares of Colliers International Gr (NASDAQ:CIGI) (TSE:CIGI) from a buy rating to a hold rating in a research report released on Wednesday morning.
Top Low Price Stocks To Buy Right Now: Basilea Pharmaceutica Ltd. (BPMUF)
Advisors’ Opinion:
- [By ]
Basilea Pharmaceuticals (OTC:BPMUF)
BPMUF Is a Swiss company with commercialized products in the anti-infection space, but they are also working on agents in cancer research. One of these agents, BAL101553, is a prodrug of a so-called tumor checkpoint controller inhibitor, which destabilizes microtubules to disrupt dividing cells. This phase 1/2a study assessed the safety and the recommended dosage for this agent. The phase 1 portion of the trial recruited 20 patients to receive various doses of BAL101553.
Top Low Price Stocks To Buy Right Now: Athene Holding Ltd. (ATH)
Advisors’ Opinion:
- [By Max Byerly]
Athabasca Oil (TSE:ATH) had its price objective hoisted by Raymond James from C$2.00 to C$2.50 in a research report released on Tuesday morning.
Other research analysts also recently issued research reports about the company. GMP Securities increased their price objective on Athabasca Oil from C$1.65 to C$2.25 in a report on Tuesday, May 15th. TD Securities upped their target price on Athabasca Oil from C$1.75 to C$2.25 and gave the company a buy rating in a research report on Thursday, May 10th. BMO Capital Markets upped their target price on Athabasca Oil from C$1.60 to C$2.25 and gave the company a market perform rating in a research report on Thursday, May 10th. Finally, Royal Bank of Canada upped their target price on Athabasca Oil from C$2.00 to C$2.50 and gave the company an outperform rating in a research report on Thursday, May 10th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of C$2.23.
- [By Max Byerly]
Athabasca Oil (TSE:ATH) had its price objective upped by Royal Bank of Canada from C$2.00 to C$2.50 in a report released on Thursday. The firm presently has an “outperform” rating on the oil and gas exploration company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 30.89% from the company’s current price.
- [By Stephan Byrd]
Athene Holding Ltd (NYSE:ATH) has received an average rating of “Buy” from the sixteen ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have issued a buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $62.10.
Top Low Price Stocks To Buy Right Now: Civitas Solutions, Inc.(CIVI)
Advisors’ Opinion:
- [By Stephan Byrd]
Balter Liquid Alternatives LLC acquired a new position in shares of Civitas Solutions (NYSE:CIVI) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,572 shares of the company’s stock, valued at approximately $178,000.
- [By Lisa Levin]
Companies Reporting After The Bell
NVIDIA Corporation (NASDAQ: NVDA) is estimated to post quarterly earnings at $1.45 per share on revenue of $2.89 billion.
News Corporation (NASDAQ: NWSA) is projected to post quarterly earnings at $0.07 per share on revenue of $1.99 billion.
Symantec Corporation (NASDAQ: SYMC) is estimated to post quarterly earnings at $0.39 per share on revenue of $1.19 billion.
Pilgrim's Pride Corporation (NASDAQ: PPC) is projected to post quarterly earnings at $0.54 per share on revenue of $2.65 billion.
Hawaiian Electric Industries, Inc. (NYSE: HE) is expected to post quarterly earnings at $0.38 per share on revenue of $556.81 million.
Air Lease Corporation (NYSE: AL) is estimated to post quarterly earnings at $1.01 per share on revenue of $383.37 million.
Flowserve Corporation (NYSE: FLS) is expected to post quarterly earnings at $0.27 per share on revenue of $880.89 million.
Civitas Solutions, Inc. (NYSE: CIVI) is projected to post quarterly earnings at $0.12 per share on revenue of $396.25 million.
The Trade Desk, Inc. (NASDAQ: TTD) is estimated to post quarterly earnings at $0.1 per share on revenue of $73.23 million.
Amdocs Limited (NYSE: DOX) is projected to post quarterly earnings at $0.95 per share on revenue of $980.50 million.
Yelp Inc. (NYSE: YELP) is estimated to post quarterly loss at $0.04 per share on revenue of $220.14 million.
Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) is expected to post quarterly earnings at $0.43 per share on revenue of $210.01 million.
TiVo Corporation (NASDAQ: TIVO) is projected to post quarterly earnings at $0.37 per share on revenue of $198.62 million.
Ritchie Bros. Auctioneers Incorporated (NYSE: RBA) is expected to post quarterly earnings at $0.17 per share on revenue of $153.87 million.
Uniti Group Inc. (NASDAQ: UNIT) is estimated to post quarterly earnings at $0.01 per share on revenue of $247.16 million.
Jagged Peak En - [By Max Byerly]
Get a free copy of the Zacks research report on Civitas Solutions (CIVI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
